Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Happy to share results of investigator initiated trial of Ruxolitinib in Ph-Like ALL. We did not see any significant responses in R/R adult Ph-like B-ALL with ruxolitinib.

Looking back at my emails Marina Konopleva and I had initial discussions with Incyte for this trial at ASH 2013! First patient enrolled Oct 2015. Thanks much Hannah Goulart for helping summarize the trial.”

Title: A Phase I/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia

Authors: Hannah Goulart, Elias Jabbour, Nicholas J. Short, Tapan M. Kadia, Naveen Pemmaraju, Koichi Takahashi, Farhad Ravandi, Marina Konopleva, Nitin Jain

Read the Full Article.

Nitin Jain

Nitin Jain: Happy to share results of investigator initiated trial of Ruxolitinib in Ph-Like ALL

“Happy to share results of investigator initiated trial of Ruxolitinib in Ph-Like ALL. We did not see any significant responses in R/R adult Ph-like B-ALL with ruxolitinib.

Looking back at my emails Marina Konopleva and I had initial discussions with Incyte for this trial at ASH 2013! First patient enrolled Oct 2015. Thanks much Hannah Goulart for helping summarize the trial.”